- Home
- BNTC vs XOMA Comparison
BNTC vs XOMA Comparison
Compare BNTC & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- XOMA
- Stock Information
- Founded
- BNTC 1995
- XOMA 1981
- Country
- BNTC United States
- XOMA United States
- Employees
- BNTC N/A
- XOMA N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- BNTC Health Care
- XOMA Health Care
- Exchange
- BNTC Nasdaq
- XOMA Nasdaq
- Market Cap
- BNTC 335.5M
- XOMA 330.2M
- IPO Year
- BNTC N/A
- XOMA N/A
- Fundamental
- Price
- BNTC $13.24
- XOMA $32.47
- Analyst Decision
- BNTC Strong Buy
- XOMA Strong Buy
- Analyst Count
- BNTC 5
- XOMA 2
- Target Price
- BNTC $26.00
- XOMA $69.50
- AVG Volume (30 Days)
- BNTC 40.8K
- XOMA 57.0K
- Earning Date
- BNTC 09-25-2025
- XOMA 08-13-2025
- Dividend Yield
- BNTC N/A
- XOMA N/A
- EPS Growth
- BNTC N/A
- XOMA N/A
- EPS
- BNTC N/A
- XOMA N/A
- Revenue
- BNTC N/A
- XOMA $44,952,000.00
- Revenue This Year
- BNTC N/A
- XOMA $82.30
- Revenue Next Year
- BNTC N/A
- XOMA $12.59
- P/E Ratio
- BNTC N/A
- XOMA N/A
- Revenue Growth
- BNTC N/A
- XOMA 194.98
- 52 Week Low
- BNTC $8.06
- XOMA $18.35
- 52 Week High
- BNTC $17.15
- XOMA $35.23
- Technical
- Relative Strength Index (RSI)
- BNTC 59.72
- XOMA 61.79
- Support Level
- BNTC $12.57
- XOMA $32.60
- Resistance Level
- BNTC $13.33
- XOMA $34.60
- Average True Range (ATR)
- BNTC 0.60
- XOMA 1.82
- MACD
- BNTC 0.10
- XOMA 0.09
- Stochastic Oscillator
- BNTC 95.59
- XOMA 66.75
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.